Amlodipine-induced gingival hypertrophy

dc.contributor.authorYolcu A.
dc.contributor.authorAydogdu I.
dc.date.accessioned2024-07-22T08:07:16Z
dc.date.available2024-07-22T08:07:16Z
dc.date.issued2020
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1016/j.ejim.2020.06.023
dc.identifier.issn09536205
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13887
dc.language.isoEnglish
dc.publisherElsevier B.V.
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAmlodipine
dc.subjectAntihypertensive Agents
dc.subjectCalcium Channel Blockers
dc.subjectGingival Hypertrophy
dc.subjectHumans
dc.subjectHypertension
dc.subjectamlodipine
dc.subjectcaptopril
dc.subjecthemoglobin
dc.subjectmetformin
dc.subjectamlodipine
dc.subjectantihypertensive agent
dc.subjectcalcium channel blocking agent
dc.subjectadult
dc.subjectantihypertensive therapy
dc.subjectArticle
dc.subjectblood cell count
dc.subjectblood smear
dc.subjectbody weight loss
dc.subjectbone marrow biopsy
dc.subjectcase report
dc.subjectclinical article
dc.subjectdisease duration
dc.subjectdrug induced disease
dc.subjectdrug substitution
dc.subjectdrug withdrawal
dc.subjecteating
dc.subjectedema
dc.subjectgingiva bleeding
dc.subjectgingiva hypertrophy
dc.subjecthematocrit
dc.subjecthemoglobin blood level
dc.subjecthepatomegaly
dc.subjecthuman
dc.subjecthypertension
dc.subjectleukocyte count
dc.subjectmale
dc.subjectmean corpuscular volume
dc.subjectmiddle aged
dc.subjectneutrophil count
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectpallor
dc.subjectphysical examination
dc.subjectplatelet count
dc.subjecttooth brushing
dc.subjectweakness
dc.subjectgingiva hypertrophy
dc.subjecthypertension
dc.titleAmlodipine-induced gingival hypertrophy
dc.typeArticle

Files